Skip to main content

Published locations for FDA panel cautiously backs approval of short-acting IV antiplatelet drug

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel cautiously backs approval of short-acting IV antiplatelet drug

User login

  • Reset your password
  • /content/fda-panel-cautiously-backs-approval-short-acting-iv-antiplatelet-drug
  • /emed-journal/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval-short-acting
  • /ehospitalistnews/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval-short
  • /vascularspecialistonline/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval
  • /anticoagulationhub/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval-short
  • /ecardiologynews/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval-short
  • /cardiology/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval-short-acting
  • /emergencymedicine/article/98767/acute-coronary-syndromes/fda-panel-cautiously-backs-approval-short